Copyright
©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Apr 28, 2008; 14(16): 2461-2473
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2461
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2461
Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: Recent advances and future perspectives
Michael Höpfner, Institute of Physiology, Charité-Universitäts-medizin Berlin, Campus Benjamin Franklin, Berlin 14195, Germany
Detlef Schuppan, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, United States
Hans Scherübl, Klinik für Innere Medizin, Gastroenterologie und Gastrointestinale Onkologie, Klinikum am Urban, Vivantes Netzwerk für Gesundheit, Berlin 10967, Germany
Michael Höpfner, Institute of Physiology, Charité-Universitäts-medizin Berlin, Campus Benjamin Franklin, Berlin 14195, Germany
Detlef Schuppan, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, United States
Hans Scherübl, Klinik für Innere Medizin, Gastroenterologie und Gastrointestinale Onkologie, Klinikum am Urban, Vivantes Netzwerk für Gesundheit, Berlin 10967, Germany
Author contributions: Höpfner M performed data acquisition, manuscript conception and writing; Schuppan D performed clinical interpretation and writing; Scherübl H performed clinical interpretation and writing.
Correspondence to: Hans Scherübl, Professor, Klinik für Innere Medizin, Gastroenterologie und Gastrointestinale Onkologie, Klinikum Am Urban, Vivantes Netzwerk für Gesundheit, Dieffenbachstrasse 1, Berlin 10967, Germany. hans.scheruebl@vivantes.de
Telephone: + 49-30-130225201
Fax: +49-30-130225205
Received: January 14, 2008
Revised: March 15, 2008
Published online: April 28, 2008
Revised: March 15, 2008
Published online: April 28, 2008
Core Tip